In this episode of Phase Forward, Hubert Godziatkowski, founder of the Polish Atopic Disease Association (PTCA), shares how patient organizations can reshape clinical trials. With over 800,000 people in Poland affected by atopic dermatitis, PTCA is working to improve clarity in consent forms, promote ethical oversight, and build trust between sponsors and patients. The conversation explores PTCA's review of consent forms, the importance of early collaboration, and the role of advocacy groups in improving recruitment and trial accessibility.
All content for Phase Forward is the property of Podcast Series hosted by Valerie Coveney and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Phase Forward, Hubert Godziatkowski, founder of the Polish Atopic Disease Association (PTCA), shares how patient organizations can reshape clinical trials. With over 800,000 people in Poland affected by atopic dermatitis, PTCA is working to improve clarity in consent forms, promote ethical oversight, and build trust between sponsors and patients. The conversation explores PTCA's review of consent forms, the importance of early collaboration, and the role of advocacy groups in improving recruitment and trial accessibility.
Episode 19: Takeaways from CDISC TMF US Interchange
Phase Forward
11 minutes 1 second
10 months ago
Episode 19: Takeaways from CDISC TMF US Interchange
Join the conversation with Amélie Rivet, Associate Director of eTMF Operations at Innovaderm. With extensive experience managing global trials across North America, Europe, and Asia, Amélie brings a deep understanding of the clinical steps essential for successful trials, from start-up to close-out. Well-versed in regulatory requirements and skilled in managing multidisciplinary teams, she will share key insights from the CDISC TMF US Interchange conference held in Arizona last October. Tune in to gain valuable knowledge and stay informed about the latest trends in TMF management.
Phase Forward
In this episode of Phase Forward, Hubert Godziatkowski, founder of the Polish Atopic Disease Association (PTCA), shares how patient organizations can reshape clinical trials. With over 800,000 people in Poland affected by atopic dermatitis, PTCA is working to improve clarity in consent forms, promote ethical oversight, and build trust between sponsors and patients. The conversation explores PTCA's review of consent forms, the importance of early collaboration, and the role of advocacy groups in improving recruitment and trial accessibility.
